Skip to content

Clinical study of molecular probes targeting somatostatin receptor 2 (SSTR2)

Clinical study of molecular probes targeting somatostatin receptor 2 (SSTR2)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093287
Enrollment
Unknown
Registered
2024-12-02
Start date
2024-12-03
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newly diagnosed malignancy or previously diagnosed malignancy

Interventions

Gold Standard: 1. Pathological examination

Sponsors

Affiliated Hospital of Guilin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years, regardless of gender; 2.Subjects must be capable of understanding and voluntarily signing the informed consent form; 3.Patients with a first diagnosis of malignant tumor or those with a history of diagnosed malignant tumors undergoing treatment.

Exclusion criteria

Exclusion criteria: 1.Critically ill patients requiring emergency intervention; 2.Individuals with a history of drug and/or alcohol abuse, or those with a history of allergic reactions; 3.Women who are planning to become pregnant, pregnant, or breastfeeding; 4.Patients with bacterial, viral, or fungal infections requiring systemic treatment; 5.Individuals whom the investigator deems unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
SUVmax;

Countries

China

Contacts

Public ContactFu Wei

The Affiliated Hospital of Guilin Medical College

13977385850@126.com+86 13977385850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026